Graves CAS

Clinical Activity Score

0/7

Inactive Phase

Guidelines & Evidence

Verified

Last Review: 2026-07-17

When to Use

Assessment Goal

The Clinical Activity Score (CAS) is used to determine if thyroid-associated ophthalmopathy (TAO) is in the active, inflammatory phase where immunosuppression (e.g. steroids, Teprotumumab) is most effective.

Last Comprehensive Review: 2026-07-17

Recent Journal Updates

British J Clinical PharmacologyJul 21, 2026

A university‐certified course on dossier assessment for regulatory scientists in Africa—Reporting on our 5‐year experience

Clinical Context

We think this has broad domain relevance to Graves Ophthalmology CSS.

Cancer MedicineJul 16, 2026

Notch3/4 Knockdown Inhibits Colon Adenocarcinoma Progression by Suppressing Tumor Cell Activity and Orchestrating VEGFA‐Dependent Tumor Immune Microenvironment

Clinical Context

We think this has broad domain relevance to Graves Ophthalmology CSS.

WHO NewsJul 15, 2026

New WHO guidelines: up to 45% of dementia risk could be prevented or delayed

Clinical Context

We think this has broad domain relevance to Graves Ophthalmology CSS.

Graves CAS

When to Use

Assessment Goal

How it Works

Initial 7 Parameters (1 pt each)

Interpretation

Recent Journal Updates

Graves CAS

When to Use

Assessment Goal

How it Works

Initial 7 Parameters (1 pt each)

Interpretation

Recent Journal Updates